On Tuesday, 30 November, European Medicines Agency (EMA) [Executive] Director Emer Cooke assured the European Parliament committee responsible for public health (ENVI) that vaccines adapted to the new SARS-CoV-2 variant—the Omicron variant—could be authorised, if need be, within three to four months.
“We know that viruses mutate, and we are prepared”, Ms Cooke repeated to MEPs, pointing out that recommendations on the subject had already been sent to Member States and...